Home

Anixa Update Call Full Transript

Operator:Good day, everyone. Welcome to today’s corporate update and discussion of recent alliance with Cleveland Clinic on breast cancer vaccine. At this time, all...

Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa to Present New 90 Day VenoValve...

Tailwinds' Take: if trends continue, the 90 day data should be very positive. We continue to believe that HJLI represents a compelling risk/reward scenario...

HyreCar Announces Pricing of $10.5 Million Public Offering of Common Stock

Tailwinds' Take: with a small discount, this deal appears to be well received by the market. HYRE is in a land-grab for market share...

Patriot One Initiates International Sales and Announces New Covert Threat Detection Platform Technology

TORONTO, July 18, 2019 (GLOBE NEWSWIRE) -- Patriot One Technologies Inc. (TSX: PAT) (OTCQX: PTOTF) (FRANKFURT: 0PL) (“Patriot One” or the “Company”), developer of...

Catasys Appoints Industry Veteran Rob Rebakto Board of Directors

Los Angeles, CA - July 18, 2019 - Catasys, Inc. (NASDAQ: CATS) ("Catasys" or the "Company"), a leading AI and technology-enabled healthcare company, today...

Anixa Licenses Another Potential Blockbuster

In January we proclaimed Anixa to be Tailwinds’ stock of the year. This designation was awarded due to potential major milestones in the both...

Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an...

SAN JOSE, Calif., July 17, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that...

Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived...

Tailwinds' Take: This is a very technical study, but here are key points: 1. George Dominguez and Amit Kumar from Anixa are co-authors with the scientists at...

PeerStream’s Partnership with YouNow Progresses as SEC Qualifies the First Consumer Reg A+ Token...

NEW YORK, NY - (NewMediaWire) - July 15, 2019 - PeerStream, Inc. (“PeerStream,” the “Company,” “we,” “our” or “us”) (OTCQB: PEER), a communications software...

Understanding The Tailwinds’ Platform

It's approaching the three-year anniversary of Tailwinds Research. A model that started out as a blog site for paid-for research has morphed into a...

HyreCar Adds Veteran Sales Executives and Scalable Customer Service Solution to Accelerate National Dealership...

LOS ANGELES, July 11, 2019 – HyreCar Inc. (NASDAQ: HYRE), the carsharing marketplace for ridesharing, has added an experienced outside sales team and scalable...

Are All The ATOMs Aligned For Atomera?

When last I visited Atomera, the Company had recently announced breakthrough performance from their MST technology, which had sparked investor interest. Timing being everything,...

HJLI: A Conversation With Dr. Steve Elias, Vascular Key Opinion Leader

Hancock Jaffe is developing their VenoValve for treatment of CVI, chronic venous insufficiency. CVI is a condition that occurs when the valves in veins...

RESONANT INC. SIGNS NEW LICENSE AGREEMENTS WITH EXISTING CUSTOMER

GOLETA, CA / ACCESSWIRE / July 9, 2019 / Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being...

The Quietest Week

Greetings from Rockport Mass, my home town and where I'm fortunate enough to be spending a couple weeks visiting family and working from an...

Four For the Fourth…The Half Year In Review

As we round out the first half of 2019, I'd like to wish a happy early birthday to America. The last six months were,...

Bioasis Engages With The FDA…Here’s What It Means

This week Bioasis heard back from the FDA on written questions they had submitted. These questions concern their lead investigational candidate xB3-001 and its...

Hancock Jaffe Reports Early Positive Results For CoreoGraft Animal Feasibility Study

Tailwinds' Take: in our opinion, and, more importantly, the Company's, the CoreoGraft is performing much better than anyone could have hoped. This product will...

Catasys Appoints Healthcare Executive Daniel Prewitt as Senior Vice President of Sales

Los Angeles, CA – June 26, 2019 – Catasys, Inc. (NASDAQ: CATS) ("Catasys" or the "Company"), a leading AI and technology-enabled healthcare company, today...

Bioasis Announces FDA Response to Pre-IND Submission

Tailwinds' Take: Positive in that the timeline for development appears to be unchanged post the meeting, so that implies there were no significant issues...

Become a Tailwinds member

Due to Tailwinds’ status as a Registered Investment Advisor, we are required to monitor our usage. Therefore you must be a Tailwinds Research member to read our articles. All articles are free for viewing, except for Premium Membership articles related to changes in the Tailwinds Select Portfolio.

Please take the time to register for a Free or Premium membership. Thank you for your support.

SIGN ME UP